Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Zogenix (United States) | Researchclopedia

Back to institutions

Zogenix (United States)

Emeryvillecompany

111

Works

10,258

Citations

52

h-index

Top Research Topics

Epilepsy research and treatment Pharmacological Effects and Toxicity Studies Neonatal and fetal brain pathology

Top Researchers

Bradley S. Galer

170 works19,530 citationsh-index: 57

Recent Research

Bringing Life to the Communiverse: Procedural Look Development in Pixar’s Elio

C. J. Burrows,Mallory Kohut,et al.

20250 citations

Neuroscience and Neuropharmacology Research

Migraine and Headache Studies

Metabolism and Genetic Disorders

Pain Mechanisms and Treatments

Lung Cancer Treatments and Mutations

Microbial Metabolic Engineering and Bioproduction

Infant Development and Preterm Care

Pain Management and Opioid Use

Trigeminal Neuralgia and Treatments

Anupam Agarwal Safdarjang Hospital

428 works19,413 citationsh-index: 73

Ben J. Boyd Australian Regenerative Medicine Institute

418 works18,733 citationsh-index: 74

80 works14,585 citationsh-index: 40

Stephanie Brown Royal Children's Hospital

339 works12,901 citationsh-index: 61

Roger Cady Springfield Clinic

302 works12,611 citationsh-index: 60

SA65 Systematic Literature Review (SLR) of Disease Burden Related to First-Line (1L) Unresectable, Locally Advanced, or Metastatic Gastric Cancer (GC) and Gastroesophageal Junction (GEJ) Adenocarcinoma

Elizabeth Smyth,Wenxi Tang,et al.

20250 citations

Publisher Correction: Controlling reactogenicity while preserving immunogenicity from a self-amplifying RNA vaccine by modulating nucleocytoplasmic transport

Jason A. Wojcechowskyj,Robyn M. Jong,et al.

20250 citations

Controlling reactogenicity while preserving immunogenicity from a self-amplifying RNA vaccine by modulating nucleocytoplasmic transport

Jason A. Wojcechowskyj,Robyn M. Jong,et al.

20254 citations

131MO Tislelizumab (TIS) plus chemotherapy (Chemo) vs placebo (PBO) plus chemo as first-line (1L) treatment of advanced gastric or gastroesophageal junction adenocarcinoma (GC/GEJC): Patient reported outcomes (PRO) in the Asian subgroup of the RATIONALE-305 study

Ken Kato,R-H. Xu,et al.

20240 citations

1417P Comparative efficacy and safety of tislelizumab versus anti-PD-1 treatments in second-line esophageal squamous cell carcinoma: Simulated treatment comparisons

E.C. Smyth,Jaffer A. Ajani,et al.

20240 citations